64 chapters · 2,529 sections in this title.
N.J.S.A. 26:2L-5 Therapeutic research qualification review board; members; appointment; compensation; duties; certification of practitioners and patients
0.9K chars
26:2L-5. Therapeutic research qualification review board; members; appointment; compensation; duties; certification of practitioners and patients a. The commissioner, after consulting with the Medical Society of New Jersey, shall appoint a Therapeutic Research Qualification Revie…
N.J.S.A. 26:2L-6 Schedule I controlled dangerous substance; agreement for receipt for purposes of act; transfer to certified practitioners for use; inapplicability of act to receipt from National Cancer Institute
1.0K chars
26:2L-6. Schedule I controlled dangerous substance; agreement for receipt for purposes of act; transfer to certified practitioners for use; inapplicability of act to receipt from National Cancer Institute a. The commissioner shall enter into an agreement with the National Institu…
N.J.S.A. 26:2L-7 Reports by participating practitioners
0.3K chars
26:2L-7. Reports by participating practitioners Participating practitioners shall submit to the commissioner reports on the use of Schedule I controlled dangerous substances received by their patients pursuant to this act. L.1981, c. 72, s. 7, eff. March 23, 1981.
Review of reports; report by board and commissioner to legislature and Governor
0.4K chars
26:2L-8. Review of reports; report by board and commissioner to legislature and Governor The board shall review all reports of use of Schedule I controlled dangerous substances in such cases, and the commissioner, in conjunction with the board, shall report his findings and recom…